NCT00003407 2023-02-02
Amifostine & High-Dose Combination Chemotherapy in Treating Patients With Acute ML or CML
Rush University Medical Center
Phase 2 Withdrawn
Rush University Medical Center
Aminex Therapeutics, Inc.
OHSU Knight Cancer Institute
Johns Hopkins University